Title : Contribution of CYP2B6 alleles in explaining extreme (S)-methadone plasma levels: a CYP2B6 gene resequencing study.

Pub. Date : 2013 Feb

PMID : 23249875






7 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Contribution of CYP2B6 alleles in explaining extreme (S)-methadone plasma levels: a CYP2B6 gene resequencing study. Methadone cytochrome P450 family 2 subfamily B member 6 Homo sapiens
2 BACKGROUND: (S)-Methadone, metabolized mainly by CYP2B6, shows a wide interindividual variability in its pharmacokinetics and pharmacodynamics. Methadone cytochrome P450 family 2 subfamily B member 6 Homo sapiens
3 METHODS: Resequencing of the CYP2B6 gene was performed in 12 and 35 selected individuals with high (S)-methadone plasma exposure and low (S)-methadone plasma exposure, respectively, from a previously described cohort of 276 patients undergoing methadone maintenance treatment. Methadone cytochrome P450 family 2 subfamily B member 6 Homo sapiens
4 METHODS: Resequencing of the CYP2B6 gene was performed in 12 and 35 selected individuals with high (S)-methadone plasma exposure and low (S)-methadone plasma exposure, respectively, from a previously described cohort of 276 patients undergoing methadone maintenance treatment. Methadone cytochrome P450 family 2 subfamily B member 6 Homo sapiens
5 METHODS: Resequencing of the CYP2B6 gene was performed in 12 and 35 selected individuals with high (S)-methadone plasma exposure and low (S)-methadone plasma exposure, respectively, from a previously described cohort of 276 patients undergoing methadone maintenance treatment. Methadone cytochrome P450 family 2 subfamily B member 6 Homo sapiens
6 CONCLUSION: Known genetic polymorphisms in CYP2B6 contribute toward explaining extreme (S)-methadone plasma levels observed in a cohort of patients following methadone maintenance treatment. Methadone cytochrome P450 family 2 subfamily B member 6 Homo sapiens
7 CONCLUSION: Known genetic polymorphisms in CYP2B6 contribute toward explaining extreme (S)-methadone plasma levels observed in a cohort of patients following methadone maintenance treatment. Methadone cytochrome P450 family 2 subfamily B member 6 Homo sapiens